Eur Rev Med Pharmacol Sci 2024; 28 (21): 4493-4506DOI: 10.26355/eurrev_202411_36908 Comparison of regimens targeting complete remission in the first-line treatment of acute myeloid leukemia patients S. Yavuz, U.Y. Malkan Free PDF Download
Eur Rev Med Pharmacol Sci 2024; 28 (9): 3384-3390DOI: 10.26355/eurrev_202405_36183 Application and prognostic relevance of CD34 detection in immunophenotyping of pediatric acute B lymphoblastic leukemia W. Zha, Y. Yuan, T. Yang, L.-J. Zhu, W.-Y. Kong, J.-J. Zhuo Free PDF Download
Eur Rev Med Pharmacol Sci 2024; 28 (8): 3135-3143DOI: 10.26355/eurrev_202404_36029 Insight into hematological parameters of petrol station workers N.K. Binsaleh, R. Eltayeb, E.M. Bashir, H.M.E. Idris, M.M. Althobiti, H.G. Ahmed, M.W.A. Khan, H. Qanash Free PDF Download
Eur Rev Med Pharmacol Sci 2024; 28 (5): 1847-1856DOI: 10.26355/eurrev_202403_35598 High expression of angiotensin-converting enzyme 2 receptor (ACE-2), transmembrane protease serine (TMPRSS), and P-selectin in platelets lead to thrombosis formation in COVID-19 patients H.A. Waggiallah, M.M. Eltayeb, A.M. Hjazi, Y.M. Elmosaad Free PDF Download
Eur Rev Med Pharmacol Sci 2024; 28 (5): 1837-1846DOI: 10.26355/eurrev_202403_35597 The efficacy and safety of venetoclax combined with demethylating agents in elderly patients with acute myeloid leukemia: a systematic review and meta-analysis M.-Y. Wei, J. Yin, Y. Liao, J.-Y. Liu, Y. Zhao, X.-M. Chen, Y. Liu, X.-M. Wang, C.-L. Huang Free PDF Download
Eur Rev Med Pharmacol Sci 2024; 28 (2): 469-476DOI: 10.26355/eurrev_202401_35046 Coexistence of multiple causes in patients with iron deficiency M. Özbilen Free PDF Download
Eur Rev Med Pharmacol Sci 2024; 28 (1): 303-309DOI: 10.26355/eurrev_202401_34917 Hemoglobin variability in patients receiving EPO and roxadustat during maintenance hemodialysis: a self-control study X. Wang, N. Zhu, W. Zeng, P. Wang Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (23): 11334-11339DOI: 10.26355/eurrev_202312_34572 The therapeutic effect of decitabine combined with HAG in acute myeloid leukemia: a retrospective case-control analysis K. Yi, S.-H. Xu, H. Cheng, S.-Y. Chen, T. Jin Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (22): 11185-11191DOI: 10.26355/eurrev_202311_34488 Evaluation of the pleth variability index, perfusion index, and other physiological parameters after COVID-19 G.Ş. Gökdemİr Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (19): 9438-9445DOI: 10.26355/eurrev_202310_33972 Investigation of hematological blood values in COVID-19 patients according to discharge and exitus groups S. Erıten Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (19): 9429-9437DOI: 10.26355/eurrev_202310_33971 Evaluation of plateletcrit level from platelet indices as a prognostic marker in COVID-19 patients S. Aydemir, F. Segmen, O. Kucuk Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (15): 6914-6916DOI: 10.26355/eurrev_202308_33262 Three is better than two: humoral response in allogeneic HSCT after the third BNT162b2 SARS-CoV-2 mRNA vaccine L. Barabino, A. Galitzia, R. Murru, G. Caocci, M. Greco, C. Targhetta, G. Angioni, A. Vacca, E. Piras, V. Frau, O. Mulas, G. La Nasa Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (13): 6058-6070DOI: 10.26355/eurrev_202307_32960 Comparative effectiveness of adding omega-3 and Manuka honey combination to conventional therapy in preventing and treating oxidative stress in pediatric β-thalassemia major – a randomized clinical trial M. Gamaleldin, I. Abraham, M. Meabed, A. Elberry, S. Abdelhalim, D. Waggas, R. Hussein Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (12): 5493-5506DOI: 10.26355/eurrev_202306_32786 Chronic myeloid leukemia, tyrosine kinase inhibitors and cardiovascular system U.Y. Malkan, I.C. Haznedaroglu Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (11): 4942-4950DOI: 10.26355/eurrev_202306_32611 Temporal relationship between thromboembolic events and myeloproliferative neoplasm diagnosis: is it associated with mortality risk? E. Gulturk, D. Yılmaz, G. Bırce Sonmezoz, M. Dırıl Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (10): 4614-4618DOI: 10.26355/eurrev_202305_32470 Do DPP-4 enzyme inhibitors affect hemoglobin, leucocyte and thrombocyte levels in patients with type 2 diabetes mellitus? F. Avcı Merdin, A. Merdin Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (10): 4570-4577DOI: 10.26355/eurrev_202305_32463 Salvage camrelizumab for an intractable NK/T cell lymphoma patient with two instances of intestinal perforation: a case report and literature review Y. Xia, Q.-H. Li, T. Liu, X.-X. Liu, H.-X. Pan, L.-L. Zhang, F. Zhu Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (10): 4520-4527DOI: 10.26355/eurrev_202305_32458 Molecular aspects of the common types of β-thalassemia mutations among Sudanese patients: a cross sectional study R.H. Elshaikh, H.E.H. Babikir, A.M.A. Babker, A.S.B. Shaya, A. Alfahed, N.S. Alharthi, A.M. Hjazi, H.A. Waggiallah Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (10): 4510-4519DOI: 10.26355/eurrev_202305_32457 Current status and hotspots evolution in myeloproliferative neoplasm: a bibliometric analysis from 2001 to 2022 M.-L. Chen, H.-C. Zhang, E.-P. Yang Free PDF Download
Eur Rev Med Pharmacol Sci 2023; 27 (8): 3514-3518DOI: 10.26355/eurrev_202304_32124 Clinical course and features of persistent polyclonal B-cell lymphocytosis with BCL-6 amplification during pregnancy A. Galitzia, R. Murru, G. Caocci, L. Barabino, A. Azzena, V.M. Licheri, M. Greco, G. La Nasa Free PDF Download